EXPERIMENTAL AND CLINICAL TRANSPLANTATION, cilt.17, sa.4, ss.536-539, 2019 (SCI-Expanded)
Objectives: In this study, we aimed to determine whether the prostate-specific antigen level is a reliable marker of prostate cancer in patients with hepatic insufficiency, based on evaluation of alterations in serum prostate-specific antigen levels after liver transplant in patients with hepatic insufficiency.